Pomdoctor says H1 2026 net loss widened as compensation lifted expenses

POM•2026-09-29

Pomdoctor reported H1 2026 net revenue up 6% to RMB 185 million and a net loss of RMB 238.17 million, including RMB 215.7 million in share-based compensation.

1. Revenue and loss

For the six months ended June 30, 2026, internet hospital revenue rose 49.3% to RMB 100.26 million, led by online pharmacy sales growth. Pharmaceutical supply chain revenue fell 21% to RMB 84.74 million as wholesale business with a large customer declined. Gross margin fell to 13.7% from 16.2%, as online pharmacy added more lower-margin best-selling products.

Sources

Pomdoctor says H1 2026 net loss widened as compensation lifted expenses

Sec

Pomdoctor says H1 2026 net loss widened as compensation lifted expenses

1. Revenue and loss

Related News

Teradyne declares dividend of R$ 0.0254650390 per unit for BRT2ERBDR006, payable Oct. 1

Acres Commercial Realty reauthorizes additional $5 million share repurchase program

Wallbox first-half 2026 loss widens to €47.94 million as revenue falls 29%

Sources

Pomdoctor says H1 2026 net loss widened as compensation lifted expenses

General Mills declares quarterly dividend of $0.61 a share

Bone Biologics holds annual shareholder meeting